{
    "Symbol": "VRTX",
    "AssetType": "Common Stock",
    "Name": "Vertex Pharmaceuticals Inc",
    "Description": "Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.",
    "CIK": "875320",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "50 NORTHERN AVENUE, BOSTON, MA, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2022-12-31",
    "MarketCapitalization": "88868200000",
    "EBITDA": "4526700000",
    "PERatio": "26.79",
    "PEGRatio": "0.413",
    "BookValue": "54.13",
    "DividendPerShare": "0",
    "DividendYield": "0",
    "EPS": "12.88",
    "RevenuePerShareTTM": "34.87",
    "ProfitMargin": "0.372",
    "OperatingMarginTTM": "0.49",
    "ReturnOnAssetsTTM": "0.173",
    "ReturnOnEquityTTM": "0.277",
    "RevenueTTM": "8930700000",
    "GrossProfitTTM": "5323100000",
    "DilutedEPSTTM": "12.88",
    "QuarterlyEarningsGrowthYOY": "0.05",
    "QuarterlyRevenueGrowthYOY": "0.111",
    "AnalystTargetPrice": "335.76",
    "TrailingPE": "26.79",
    "ForwardPE": "19.72",
    "PriceToSalesRatioTTM": "9.1",
    "PriceToBookRatio": "6.15",
    "EVToRevenue": "8.18",
    "EVToEBITDA": "16.84",
    "Beta": "0.488",
    "52WeekHigh": "354.46",
    "52WeekLow": "233.01",
    "50DayMovingAverage": "309.59",
    "200DayMovingAverage": "300.83",
    "SharesOutstanding": "257589000",
    "DividendDate": "None",
    "ExDividendDate": "None"
}